SCHEMBL20967379

SCHEMBL20967379

O=P(c1ccccc1)(c1ccccc1)c1ccc(-c2nc(-c3ccc(F)cc3)nc(-c3c(F)c(F)c(F)c(F)c3F)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 1/20 0.39
▸ ABCG2 Q9UNQ0 1/20 0.38
▸ MAPT P10636 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ PPARG P37231 1/20 0.37
▸ NCOA2 Q15596 1/20 0.37
▸ NCOA1 Q15788 1/20 0.37
▸ NCOA3 Q9Y6Q9 1/20 0.37
▸ UTRN P46939 1/20 0.37
▸ DPP4 P27487 1/20 0.37
▸ ADCY1 Q08828 3/20 0.36
▸ ADCY8 P40145 2/20 0.36
▸ ALDH1A3 P47895 1/20 0.35
▸ LMNA P02545 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ KDM1A O60341 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20967282 0.93 TOP1 (0.39) TOP1ABCG2MAPTKDM4EALDH1A1
SCHEMBL20967352 0.91 ABCG2 (0.44) TOP1ABCG2MAPTKDM4EALDH1A1
SCHEMBL20967391 0.91 ABCG2 (0.44) TOP1ABCG2MAPTKDM4EALDH1A1
SCHEMBL20967358 0.91 ABCG2 (0.44) TOP1ABCG2MAPTKDM4EALDH1A1
SCHEMBL20967383 0.91 ABCG2 (0.44) TOP1ABCG2MAPTKDM4EALDH1A1
SCHEMBL20967322 0.91 TOP1 (0.40) TOP1ABCG2MAPTKDM4EALDH1A1
SCHEMBL20967354 0.90 TOP1 (0.38) TOP1ABCG2MAPTKDM4EALDH1A1
SCHEMBL20967270 0.89 ABCG2 (0.46) TOP1ABCG2MAPTKDM4EALDH1A1
SCHEMBL20967269 0.89 ABCG2 (0.46) TOP1ABCG2MAPTKDM4EALDH1A1
SCHEMBL20967353 0.89 ABCG2 (0.46) TOP1ABCG2MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11251376-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-02-15 — — US disclosed
US-20190131535-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11251376-B2 Heterocyclic compound and organic light-emitting device including the same LAGE3, DDT, AOC2 TOP1 2383/4885ABCG2 2837/4885MAPT 1882/4885
US-20190131535-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LAGE3, DDT, AOC2 TOP1 2383/4885ABCG2 2837/4885MAPT 1882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback